POWERHOUSE PROTEOMIC SYSTEMS, LLC

Biotech · Defunct

Annotated library of fluorescently-tagged protein-trap embryonic stem cell lines for real-time protein expression profiling

Grants
$602K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Creation of a Versatile Proteomic Resource in Murine Embryonic Stem Cells$300,466
Federal grantDepartment of Health and Human Services · Phase I · Creation of a Versatile Proteomic Resource in Murine Embryonic Stem Cells$301,301
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2238KAPHA BIO, INC.——
2239Forecast Bio, Inc.—$2.4M
2240Monocacy Therapeutics Inc.—$389K
2241POWERHOUSE PROTEOMIC SYSTEMS, LLC——
2242TENSIVE CONTROLS, INC.——
2243Acelyrin——
2244Cour Pharmaceutical——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.